Evidence map›Paper›PMID 37946154›Full record

ArticleBMC medical informatics and decision making2023

The consequences of data dispersion in genomics: a comparative analysis of data sources for precision medicine.

Mireia Costa, Alberto García S, Oscar Pastor

Open access · goldAbstract read
In one paragraph

Article in BMC medical informatics and decision making, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. MaveMD: A functional data resource for genomic medicine.medRxiv : the preprint server for health sciences · 2025
    Article
  3. Review of autism spectrum disorder databases for the identification of candidate genes.Database : the journal of biological databases and curation · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mireia Costa *PROS Research Center, VRAIN Research Institute, Universitat Politècnica de València, Camino de Vera, Valencia, Spain. micossan@vrain.upv.es.ORCID 0000-0002-8614-0914
Alberto García S *PROS Research Center, VRAIN Research Institute, Universitat Politècnica de València, Camino de Vera, Valencia, Spain.
Oscar PastorPROS Research Center, VRAIN Research Institute, Universitat Politècnica de València, Camino de Vera, Valencia, Spain.
Universitat Politècnica de València · ES

Funding

Agencia Estatal de Investigación PDC2021-121243-I00Agencia Estatal de Investigación PID2021-123824OB-I0Agència Valenciana de la Innovació INNEST/2021/57Generalitat Valenciana ACIF/2021/117Generalitat Valenciana CIPROM/2021/023
6 · The paper itself

Abstract

backgroundGenomics-based clinical diagnosis has emerged as a novel medical approach to improve diagnosis and treatment. However, advances in sequencing techniques have increased the generation of genomics data dramatically. This has led to several data management problems, one of which is data dispersion (i.e., genomics data is scattered across hundreds of data repositories). In this context, geneticists try to remediate the above-mentioned problem by limiting the scope of their work to a single data source they know and trust. This work has studied the consequences of focusing on a single data source rather than considering the many different existing genomics data sources.

methodsThe analysis is based on the data associated with two groups of disorders (i.e., oncology and cardiology) accessible from six well-known genomic data sources (i.e., ClinVar, Ensembl, GWAS Catalog, LOVD, CIViC, and CardioDB). Two dimensions have been considered in this analysis, namely, completeness and concordance. Completeness has been evaluated at two levels. First, by analyzing the information provided by each data source with regard to a conceptual schema data model (i.e., the schema level). Second, by analyzing the DNA variations provided by each data source as related to any of the disorders selected (i.e., the data level). Concordance has been evaluated by comparing the consensus among the data sources regarding the clinical relevance of each variation and disorder.

resultsThe data sources with the highest completeness at the schema level are ClinVar, Ensembl, and CIViC. ClinVar has the highest completeness at the data level data source for the oncology and cardiology disorders. However, there are clinically relevant variations that are exclusive to other data sources, and they must be considered in order to provide the best clinical diagnosis. Although the information available in the data sources is predominantly concordant, discordance among the analyzed data exist. This can lead to inaccurate diagnoses.

conclusionPrecision medicine analyses using a single genomics data source leads to incomplete results. Also, there are concordance problems that threaten the correctness of the genomics-based diagnosis results.

Indexed as

Information SourcesPrecision MedicineGenomeGenomicsHumansMedical OncologyCompletenessConcordanceDNA variationsGenomic data sourcesPrecision medicine

Identifiers

PMID37946154
PMCPMC10636939
OpenAlexW4388526551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.